BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 14982688)

  • 1. A multicenter, randomized, double-blind, placebo-controlled, 6-month trial of bupropion hydrochloride sustained-release tablets as an aid to smoking cessation in hospital employees.
    Dalsgareth OJ; Hansen NC; Søes-Petersen U; Evald T; Høegholm A; Barber J; Vestbo J
    Nicotine Tob Res; 2004 Feb; 6(1):55-61. PubMed ID: 14982688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
    Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR
    Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between drug exposure and the efficacy and safety of bupropion sustained release for smoking cessation.
    Johnston JA; Fiedler-Kelly J; Glover ED; Sachs DP; Grasela TH; DeVeaugh-Geiss J
    Nicotine Tob Res; 2001 May; 3(2):131-40. PubMed ID: 11403727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained-release bupropion for hospital-based smoking cessation: a randomized trial.
    Simon JA; Duncan C; Huggins J; Solkowitz S; Carmody TP
    Nicotine Tob Res; 2009 Jun; 11(6):663-9. PubMed ID: 19395688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial.
    Aubin HJ; Lebargy F; Berlin I; Bidaut-Mazel C; Chemali-Hudry J; Lagrue G
    Addiction; 2004 Sep; 99(9):1206-18. PubMed ID: 15317642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind, placebo-controlled, randomized trial of bupropion for smoking cessation in primary care.
    Fossati R; Apolone G; Negri E; Compagnoni A; La Vecchia C; Mangano S; Clivio L; Garattini S;
    Arch Intern Med; 2007 Sep; 167(16):1791-7. PubMed ID: 17846399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia.
    Evins AE; Mays VK; Rigotti NA; Tisdale T; Cather C; Goff DC
    Nicotine Tob Res; 2001 Nov; 3(4):397-403. PubMed ID: 11694208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of sustained-release bupropion and placebo for smoking cessation.
    Hurt RD; Sachs DP; Glover ED; Offord KP; Johnston JA; Dale LC; Khayrallah MA; Schroeder DR; Glover PN; Sullivan CR; Croghan IT; Sullivan PM
    N Engl J Med; 1997 Oct; 337(17):1195-202. PubMed ID: 9337378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
    Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
    J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled clinical trial of bupropion SR and individual smoking cessation counseling.
    McCarthy DE; Piasecki TM; Lawrence DL; Jorenby DE; Shiffman S; Fiore MC; Baker TB
    Nicotine Tob Res; 2008 Apr; 10(4):717-29. PubMed ID: 18418793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counseling.
    Collins BN; Wileyto EP; Patterson F; Rukstalis M; Audrain-McGovern J; Kaufmann V; Pinto A; Hawk L; Niaura R; Epstein LH; Lerman C
    Nicotine Tob Res; 2004 Feb; 6(1):27-37. PubMed ID: 14982685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial of bupropion and/or nicotine gum as maintenance treatment for preventing smoking relapse.
    Covey LS; Glassman AH; Jiang H; Fried J; Masmela J; LoDuca C; Petkova E; Rodriguez K
    Addiction; 2007 Aug; 102(8):1292-302. PubMed ID: 17624979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The participation of health professionals in a smoking-cessation programme positively influences the smoking cessation advice given to patients.
    Puska PM; Barrueco M; Roussos C; Hider A; Hogue S
    Int J Clin Pract; 2005 Apr; 59(4):447-52. PubMed ID: 15853863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of bupropion in the indigenous Maori population in New Zealand.
    Holt S; Timu-Parata C; Ryder-Lewis S; Weatherall M; Beasley R
    Thorax; 2005 Feb; 60(2):120-3. PubMed ID: 15681499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease.
    Wagena EJ; Knipschild PG; Huibers MJ; Wouters EF; van Schayck CP
    Arch Intern Med; 2005 Oct; 165(19):2286-92. PubMed ID: 16246996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A bupropion smoking cessation clinical trial for cancer patients.
    Schnoll RA; Martinez E; Tatum KL; Weber DM; Kuzla N; Glass M; Ridge JA; Langer C; Miyamoto C; Wileyto EP; Leone F
    Cancer Causes Control; 2010 Jun; 21(6):811-20. PubMed ID: 20087643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bupropion for smoking cessation: a randomized trial.
    Simon JA; Duncan C; Carmody TP; Hudes ES
    Arch Intern Med; 2004 Sep; 164(16):1797-803. PubMed ID: 15364675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bupropion sustained release added to group support for smoking cessation in schizophrenia: a new randomized trial and a meta-analysis.
    Weiner E; Ball MP; Buchholz AS; Gold JM; Evins AE; McMahon RP; Buchanan RW
    J Clin Psychiatry; 2012 Jan; 73(1):95-102. PubMed ID: 21535998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A smoking ban in public places increases the efficacy of bupropion and counseling on cessation outcomes at 1 year.
    Grassi MC; Enea D; Ferketich AK; Lu B; Nencini P
    Nicotine Tob Res; 2009 Sep; 11(9):1114-21. PubMed ID: 19654237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
    Jorenby DE; Hays JT; Rigotti NA; Azoulay S; Watsky EJ; Williams KE; Billing CB; Gong J; Reeves KR;
    JAMA; 2006 Jul; 296(1):56-63. PubMed ID: 16820547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.